Global Arthritis Monoclonal Antibodies Market Size, Status and Forecast 2024-2031

Report ID: 919288 | Published Date: Sep 2024 | No. of Page: 98 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Remicade
        1.2.3 Humira
        1.2.4 Enbrel
        1.2.5 Rituxan
        1.2.6 Orencia
        1.2.7 Actemra
        1.2.8 Simponi
        1.2.9 Cimzia
    1.3 Market by Application
        1.3.1 Global Arthritis Monoclonal Antibodies Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Rheumatoid Arthritis
        1.3.3 Osteoarthritis
        1.3.4 Psoriatic Arthritis
        1.3.5 Ankylosing Spondylitis
        1.3.6 Fibromyalgia
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Arthritis Monoclonal Antibodies Market Perspective (2016-2027)
    2.2 Arthritis Monoclonal Antibodies Growth Trends by Regions
        2.2.1 Arthritis Monoclonal Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Arthritis Monoclonal Antibodies Historic Market Share by Regions (2016-2021)
        2.2.3 Arthritis Monoclonal Antibodies Forecasted Market Size by Regions (2022-2027)
    2.3 Arthritis Monoclonal Antibodies Industry Dynamic
        2.3.1 Arthritis Monoclonal Antibodies Market Trends
        2.3.2 Arthritis Monoclonal Antibodies Market Drivers
        2.3.3 Arthritis Monoclonal Antibodies Market Challenges
        2.3.4 Arthritis Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue
        3.1.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue (2016-2021)
        3.1.2 Global Arthritis Monoclonal Antibodies Revenue Market Share by Players (2016-2021)
    3.2 Global Arthritis Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Arthritis Monoclonal Antibodies Revenue
    3.4 Global Arthritis Monoclonal Antibodies Market Concentration Ratio
        3.4.1 Global Arthritis Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Arthritis Monoclonal Antibodies Revenue in 2020
    3.5 Arthritis Monoclonal Antibodies Key Players Head office and Area Served
    3.6 Key Players Arthritis Monoclonal Antibodies Product Solution and Service
    3.7 Date of Enter into Arthritis Monoclonal Antibodies Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Arthritis Monoclonal Antibodies Breakdown Data by Type
    4.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Type (2016-2021)
    4.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2022-2027)

5 Arthritis Monoclonal Antibodies Breakdown Data by Application
    5.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Application (2016-2021)
    5.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Arthritis Monoclonal Antibodies Market Size (2016-2027)
    6.2 North America Arthritis Monoclonal Antibodies Market Size by Type
        6.2.1 North America Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
        6.2.2 North America Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
        6.2.3 North America Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
    6.3 North America Arthritis Monoclonal Antibodies Market Size by Application
        6.3.1 North America Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
        6.3.2 North America Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
        6.3.3 North America Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
    6.4 North America Arthritis Monoclonal Antibodies Market Size by Country
        6.4.1 North America Arthritis Monoclonal Antibodies Market Size by Country (2016-2021)
        6.4.2 North America Arthritis Monoclonal Antibodies Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Arthritis Monoclonal Antibodies Market Size (2016-2027)
    7.2 Europe Arthritis Monoclonal Antibodies Market Size by Type
        7.2.1 Europe Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
        7.2.2 Europe Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
        7.2.3 Europe Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
    7.3 Europe Arthritis Monoclonal Antibodies Market Size by Application
        7.3.1 Europe Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
        7.3.2 Europe Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
        7.3.3 Europe Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
    7.4 Europe Arthritis Monoclonal Antibodies Market Size by Country
        7.4.1 Europe Arthritis Monoclonal Antibodies Market Size by Country (2016-2021)
        7.4.2 Europe Arthritis Monoclonal Antibodies Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size (2016-2027)
    8.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type
        8.2.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
    8.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application
        8.3.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
    8.4 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region
        8.4.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Arthritis Monoclonal Antibodies Market Size (2016-2027)
    9.2 Latin America Arthritis Monoclonal Antibodies Market Size by Type
        9.2.1 Latin America Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
        9.2.2 Latin America Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
        9.2.3 Latin America Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
    9.3 Latin America Arthritis Monoclonal Antibodies Market Size by Application
        9.3.1 Latin America Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
        9.3.2 Latin America Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
        9.3.3 Latin America Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
    9.4 Latin America Arthritis Monoclonal Antibodies Market Size by Country
        9.4.1 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2016-2021)
        9.4.2 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size (2016-2027)
    10.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type
        10.2.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
    10.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application
        10.3.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
    10.4 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country
        10.4.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie Inc
        11.1.1 AbbVie Inc Company Details
        11.1.2 AbbVie Inc Business Overview
        11.1.3 AbbVie Inc Arthritis Monoclonal Antibodies Introduction
        11.1.4 AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.1.5 AbbVie Inc Recent Development
    11.2 F. Hoffmann-La Roche Ltd
        11.2.1 F. Hoffmann-La Roche Ltd Company Details
        11.2.2 F. Hoffmann-La Roche Ltd Business Overview
        11.2.3 F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Introduction
        11.2.4 F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.2.5 F. Hoffmann-La Roche Ltd Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Arthritis Monoclonal Antibodies Introduction
        11.3.4 Novartis Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.3.5 Novartis Recent Development
    11.4 Johnson & Johnson(Janssen)
        11.4.1 Johnson & Johnson(Janssen) Company Details
        11.4.2 Johnson & Johnson(Janssen) Business Overview
        11.4.3 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Introduction
        11.4.4 Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.4.5 Johnson & Johnson(Janssen) Recent Development
    11.5 Pfizer Inc
        11.5.1 Pfizer Inc Company Details
        11.5.2 Pfizer Inc Business Overview
        11.5.3 Pfizer Inc Arthritis Monoclonal Antibodies Introduction
        11.5.4 Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.5.5 Pfizer Inc Recent Development
    11.6 Mylan
        11.6.1 Mylan Company Details
        11.6.2 Mylan Business Overview
        11.6.3 Mylan Arthritis Monoclonal Antibodies Introduction
        11.6.4 Mylan Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.6.5 Mylan Recent Development
    11.7 Genentech
        11.7.1 Genentech Company Details
        11.7.2 Genentech Business Overview
        11.7.3 Genentech Arthritis Monoclonal Antibodies Introduction
        11.7.4 Genentech Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.7.5 Genentech Recent Development
    11.8 GSK
        11.8.1 GSK Company Details
        11.8.2 GSK Business Overview
        11.8.3 GSK Arthritis Monoclonal Antibodies Introduction
        11.8.4 GSK Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.8.5 GSK Recent Development
    11.9 AstraZeneca PLC
        11.9.1 AstraZeneca PLC Company Details
        11.9.2 AstraZeneca PLC Business Overview
        11.9.3 AstraZeneca PLC Arthritis Monoclonal Antibodies Introduction
        11.9.4 AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
        11.9.5 AstraZeneca PLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Remicade
    Table 3. Key Players of Humira
    Table 4. Key Players of Enbrel
    Table 5. Key Players of Rituxan
    Table 6. Key Players of Orencia
    Table 7. Key Players of Actemra
    Table 8. Key Players of Simponi
    Table 9. Key Players of Cimzia
    Table 10. Global Arthritis Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Arthritis Monoclonal Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 12. Global Arthritis Monoclonal Antibodies Market Size by Regions (2016-2021) & (US$ Million)
    Table 13. Global Arthritis Monoclonal Antibodies Market Share by Regions (2016-2021)
    Table 14. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 15. Global Arthritis Monoclonal Antibodies Market Share by Regions (2022-2027)
    Table 16. Arthritis Monoclonal Antibodies Market Trends
    Table 17. Arthritis Monoclonal Antibodies Market Drivers
    Table 18. Arthritis Monoclonal Antibodies Market Challenges
    Table 19. Arthritis Monoclonal Antibodies Market Restraints
    Table 20. Global Arthritis Monoclonal Antibodies Revenue by Players (2016-2021) & (US$ Million)
    Table 21. Global Arthritis Monoclonal Antibodies Market Share by Players (2016-2021)
    Table 22. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Monoclonal Antibodies as of 2020)
    Table 23. Ranking of Global Top Arthritis Monoclonal Antibodies Companies by Revenue (US$ Million) in 2020
    Table 24. Global 5 Largest Players Market Share by Arthritis Monoclonal Antibodies Revenue (CR5 and HHI) & (2016-2021)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Arthritis Monoclonal Antibodies Product Solution and Service
    Table 27. Date of Enter into Arthritis Monoclonal Antibodies Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
    Table 30. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
    Table 31. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 32. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 33. Global Arthritis Monoclonal Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
    Table 34. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2016-2021)
    Table 35. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 36. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 37. North America Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
    Table 38. North America Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
    Table 39. North America Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
    Table 40. North America Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
    Table 41. North America Arthritis Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. North America Arthritis Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Europe Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
    Table 44. Europe Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Europe Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
    Table 46. Europe Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Europe Arthritis Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million) 
    Table 48. Europe Arthritis Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million) 
    Table 49. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
    Table 52. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2016-2021) & (US$ Million) 
    Table 54. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2022-2027) & (US$ Million) 
    Table 55. Latin America Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
    Table 56. Latin America Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Latin America Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
    Table 58. Latin America Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
    Table 64. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
    Table 65. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million) 
    Table 66. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million) 
    Table 67. AbbVie Inc Company Details
    Table 68. AbbVie Inc Business Overview
    Table 69. AbbVie Inc Arthritis Monoclonal Antibodies Product
    Table 70. AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 71. AbbVie Inc Recent Development
    Table 72. F. Hoffmann-La Roche Ltd Company Details
    Table 73. F. Hoffmann-La Roche Ltd Business Overview
    Table 74. F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Product
    Table 75. F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 76. F. Hoffmann-La Roche Ltd Recent Development
    Table 77. Novartis Company Details
    Table 78. Novartis Business Overview
    Table 79. Novartis Arthritis Monoclonal Antibodies Product
    Table 80. Novartis Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 81. Novartis Recent Development
    Table 82. Johnson & Johnson(Janssen) Company Details
    Table 83. Johnson & Johnson(Janssen) Business Overview
    Table 84. Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Product
    Table 85. Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 86. Johnson & Johnson(Janssen) Recent Development
    Table 87. Pfizer Inc Company Details
    Table 88. Pfizer Inc Business Overview
    Table 89. Pfizer Inc Arthritis Monoclonal Antibodies Product
    Table 90. Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 91. Pfizer Inc Recent Development
    Table 92. Mylan Company Details
    Table 93. Mylan Business Overview
    Table 94. Mylan Arthritis Monoclonal Antibodies Product
    Table 95. Mylan Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 96. Mylan Recent Development
    Table 97. Genentech Company Details
    Table 98. Genentech Business Overview
    Table 99. Genentech Arthritis Monoclonal Antibodies Product
    Table 100. Genentech Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 101. Genentech Recent Development
    Table 102. GSK Company Details
    Table 103. GSK Business Overview
    Table 104. GSK Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 105. GSK Recent Development
    Table 106. AstraZeneca PLC Company Details
    Table 107. AstraZeneca PLC Business Overview
    Table 108. AstraZeneca PLC Arthritis Monoclonal Antibodies Product
    Table 109. AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
    Table 110. AstraZeneca PLC Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Arthritis Monoclonal Antibodies Market Share by Type: 2020 VS 2027
    Figure 2. Remicade Features
    Figure 3. Humira Features
    Figure 4. Enbrel Features
    Figure 5. Rituxan Features
    Figure 6. Orencia Features
    Figure 7. Actemra Features
    Figure 8. Simponi Features
    Figure 9. Cimzia Features
    Figure 10. Global Arthritis Monoclonal Antibodies Market Share by Application: 2020 VS 2027
    Figure 11. Rheumatoid Arthritis Case Studies
    Figure 12. Osteoarthritis Case Studies
    Figure 13. Psoriatic Arthritis Case Studies
    Figure 14. Ankylosing Spondylitis Case Studies
    Figure 15. Fibromyalgia Case Studies
    Figure 16. Others Case Studies
    Figure 17. Arthritis Monoclonal Antibodies Report Years Considered
    Figure 18. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 19. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 20. Global Arthritis Monoclonal Antibodies Market Share by Regions: 2020 VS 2027
    Figure 21. Global Arthritis Monoclonal Antibodies Market Share by Regions (2022-2027)
    Figure 22. Global Arthritis Monoclonal Antibodies Market Share by Players in 2020
    Figure 23. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Monoclonal Antibodies as of 2020
    Figure 24. The Top 10 and 5 Players Market Share by Arthritis Monoclonal Antibodies Revenue in 2020
    Figure 25. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
    Figure 26. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2022-2027)
    Figure 27. North America Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. North America Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
    Figure 29. North America Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
    Figure 30. North America Arthritis Monoclonal Antibodies Market Share by Country (2016-2027)
    Figure 31. United States Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Canada Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Europe Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
    Figure 35. Europe Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
    Figure 36. Europe Arthritis Monoclonal Antibodies Market Share by Country (2016-2027)
    Figure 37. Germany Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. France Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. U.K. Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Italy Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Russia Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Nordic Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
    Figure 45. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
    Figure 46. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Region (2016-2027)
    Figure 47. China Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Japan Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. South Korea Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Southeast Asia Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. India Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Australia Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Latin America Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
    Figure 55. Latin America Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
    Figure 56. Latin America Arthritis Monoclonal Antibodies Market Share by Country (2016-2027)
    Figure 57. Mexico Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Brazil Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
    Figure 61. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
    Figure 62. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Country (2016-2027)
    Figure 63. Turkey Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Saudi Arabia Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. UAE Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 66. AbbVie Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 67. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 68. Novartis Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 69. Johnson & Johnson(Janssen) Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 70. Pfizer Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 71. Mylan Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 72. Genentech Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 73. GSK Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 74. AstraZeneca PLC Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie Inc
F. Hoffmann-La Roche Ltd
Novartis
Johnson & Johnson(Janssen)
Pfizer Inc
Mylan
Genentech
GSK
AstraZeneca PLC
Frequently Asked Questions
Arthritis Monoclonal Antibodies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Arthritis Monoclonal Antibodies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Arthritis Monoclonal Antibodies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Inhalation Sedatives

Inhalation Sedatives are the drugs used to induce or maintain inhalation sedation, which is a typ ... Read More